Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

Related Citations for PubMed (Select 23407552)

1.

The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma.

Meissner B, Kridel R, Lim RS, Rogic S, Tse K, Scott DW, Moore R, Mungall AJ, Marra MA, Connors JM, Steidl C, Gascoyne RD.

Blood. 2013 Apr 18;121(16):3161-4. doi: 10.1182/blood-2013-01-478834. Epub 2013 Feb 13.

2.

Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.

Greiner TC, Dasgupta C, Ho VV, Weisenburger DD, Smith LM, Lynch JC, Vose JM, Fu K, Armitage JO, Braziel RM, Campo E, Delabie J, Gascoyne RD, Jaffe ES, Muller-Hermelink HK, Ott G, Rosenwald A, Staudt LM, Im MY, Karaman MW, Pike BL, Chan WC, Hacia JG.

Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2352-7. Epub 2006 Feb 3.

3.

Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma.

Kridel R, Meissner B, Rogic S, Boyle M, Telenius A, Woolcock B, Gunawardana J, Jenkins C, Cochrane C, Ben-Neriah S, Tan K, Morin RD, Opat S, Sehn LH, Connors JM, Marra MA, Weng AP, Steidl C, Gascoyne RD.

Blood. 2012 Mar 1;119(9):1963-71. doi: 10.1182/blood-2011-11-391474. Epub 2011 Dec 30.

4.

Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.

Beà S, Valdés-Mas R, Navarro A, Salaverria I, Martín-Garcia D, Jares P, Giné E, Pinyol M, Royo C, Nadeu F, Conde L, Juan M, Clot G, Vizán P, Di Croce L, Puente DA, López-Guerra M, Moros A, Roue G, Aymerich M, Villamor N, Colomo L, Martínez A, Valera A, Martín-Subero JI, Amador V, Hernández L, Rozman M, Enjuanes A, Forcada P, Muntañola A, Hartmann EM, Calasanz MJ, Rosenwald A, Ott G, Hernández-Rivas JM, Klapper W, Siebert R, Wiestner A, Wilson WH, Colomer D, López-Guillermo A, López-Otín C, Puente XS, Campo E.

Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18250-5. doi: 10.1073/pnas.1314608110. Epub 2013 Oct 21.

5.

ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances.

Camacho E, Hernández L, Hernández S, Tort F, Bellosillo B, Beà S, Bosch F, Montserrat E, Cardesa A, Fernández PL, Campo E.

Blood. 2002 Jan 1;99(1):238-44.

6.

Absence of ATM hypermethylation in mantle cell and follicular lymphoma.

Chim CS, Wong KY, Loong F, Srivastava G.

Leukemia. 2005 May;19(5):880-2. No abstract available.

PMID:
15744354
7.

Mantle cell lymphoma is characterized by inactivation of the ATM gene.

Schaffner C, Idler I, Stilgenbauer S, Döhner H, Lichter P.

Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2773-8.

8.

Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma.

Fang NY, Greiner TC, Weisenburger DD, Chan WC, Vose JM, Smith LM, Armitage JO, Mayer RA, Pike BL, Collins FS, Hacia JG.

Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5372-7. Epub 2003 Apr 15.

9.

Familial lymphoid neoplasms in patients with mantle cell lymphoma.

Tort F, Camacho E, Bosch F, Harris NL, Montserrat E, Campo E.

Haematologica. 2004 Mar;89(3):314-9.

10.

Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL.

Austen B, Powell JE, Alvi A, Edwards I, Hooper L, Starczynski J, Taylor AM, Fegan C, Moss P, Stankovic T.

Blood. 2005 Nov 1;106(9):3175-82. Epub 2005 Jul 12.

11.

The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells.

Zhang J, Jima D, Moffitt AB, Liu Q, Czader M, Hsi ED, Fedoriw Y, Dunphy CH, Richards KL, Gill JI, Sun Z, Love C, Scotland P, Lock E, Levy S, Hsu DS, Dunson D, Dave SS.

Blood. 2014 May 8;123(19):2988-96. doi: 10.1182/blood-2013-07-517177. Epub 2014 Mar 28.

PMID:
24682267
12.

ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.

Dornan D, Shimizu H, Mah A, Dudhela T, Eby M, O'rourke K, Seshagiri S, Dixit VM.

Science. 2006 Aug 25;313(5790):1122-6.

13.

ATM mutations in sporadic lymphoid tumours.

Stankovic T, Stewart GS, Byrd P, Fegan C, Moss PA, Taylor AM.

Leuk Lymphoma. 2002 Aug;43(8):1563-71. Review.

PMID:
12400598
14.

The ATM gene in the pathogenesis of mantle-cell lymphoma.

Stilgenbauer S, Schaffner C, Winkler D, Ott G, Leupolt E, Bentz M, Möller P, Müller-Hermelink HK, James MR, Lichter P, Döhner H.

Ann Oncol. 2000;11 Suppl 1:127-30.

PMID:
10707794
15.

Characterization of genetic changes in MCL by interphase FISH on tissue sections.

Sander B, Wallblom A, Ekroth A, Porwit A, Kimby E.

Leuk Lymphoma. 2007 Jul;48(7):1344-52.

PMID:
17613764
16.

Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia.

Vorechovský I, Luo L, Dyer MJ, Catovsky D, Amlot PL, Yaxley JC, Foroni L, Hammarström L, Webster AD, Yuille MA.

Nat Genet. 1997 Sep;17(1):96-9.

PMID:
9288106
17.

ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma.

Grønbaek K, Worm J, Ralfkiaer E, Ahrenkiel V, Hokland P, Guldberg P.

Blood. 2002 Aug 15;100(4):1430-7.

18.

Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.

Chiarle R, Budel LM, Skolnik J, Frizzera G, Chilosi M, Corato A, Pizzolo G, Magidson J, Montagnoli A, Pagano M, Maes B, De Wolf-Peeters C, Inghirami G.

Blood. 2000 Jan 15;95(2):619-26.

19.

Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma.

Stilgenbauer S, Winkler D, Ott G, Schaffner C, Leupolt E, Bentz M, Möller P, Müller-Hermelink HK, James MR, Lichter P, Döhner H.

Blood. 1999 Nov 1;94(9):3262-4.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk